logo-loader
viewHaydale Graphene Inds PLC

Haydale Graphene 'entering new growth phase' with commercial deal for its inks

Ray Gibbs, president of business development at Haydale Graphene Industries PLC (LON:HAYD), updates Proactive London's Andrew Scott on a number of their recent announcements including this morning's news that they've begun to ship commercial quantities of its graphene ink for diabetes test strips.

Trials have been underway for a year by the customer, but sizeable deliveries have now started as part of a 100kg order.

Quick facts: Haydale Graphene Inds PLC

Price: 4.003 GBX

LSE:HAYD
Market: LSE
Market Cap: £13.62 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

PredictMedix files two U.S. patents for technology while seeing big growth...

PredictMedix (CSE: PMED- OTCQB: PMEDF) CEO Dr Rahul Kushwah, Thomas Loftus, Director with Taurus Medical Solutions, and Dr Arun Chauhan with Vital healthcare Group joined Steve Darling from Proactive to a number of issues. Dr Kushwah shared with Proactive that the company has filed two...

4 hours, 36 minutes ago

2 min read